Biomedical applications of natural-based polymers combined with bioactive glass nanoparticles by Leite, Álvaro J. & Mano, J. F.
This journal is©The Royal Society of Chemistry 2017 J. Mater. Chem. B, 2017, 5, 4555--4568 | 4555
Cite this: J.Mater. Chem. B, 2017,
5, 4555
Biomedical applications of natural-based polymers
combined with bioactive glass nanoparticles
A´. J. Leite ab and J. F. Mano *abc
In recent years, the combination of natural polymers with nanoparticles has permitted the development
of sophisticated and eﬃcient bioinspired constructs. In this regard, the incorporation of bioactive glass
nanoparticles (BGNPs) confers a bioactive nature to these constructs, which can then induce the
formation of a bone-like apatite layer upon immersion in a physiological environment. Moreover, the
incorporation of bioactive glass nanoparticles has been found to be beneficial; the constructs proved to
be biocompatible, promote cell adhesion and spreading, and regulate osteogenic commitment. This
review provides a summary and discussion of the composition, design, and applications of bioinspired
nanocomposite constructs based on BGNPs. Examples of nanocomposite systems will be highlighted
with relevance to biomedical applications. It is expected that understanding the principles and the state-
of-the-art of natural nanocomposites may lead to breakthroughs in many research areas, including tissue
engineering and orthopaedic devices. The challenges regarding the future translation of these nanostructured
composites into clinical use are also summarized.
Introduction
Bioactive glass-based materials are known for their bioactivity,
which can be applied in various fields. From an orthopedic pers-
pective, this bioactivity is due to a bonelike apatite layer that
grows on the surface of the bioactive glass upon implantation.3
This feature translates into acceptable anchorage to hard living
tissues. Moreover, it prevents complications often related to
implant failures, such as the formation of fibrous capsules,
micromotion, and patient pain.8
However, this bioactivity also enables the release of ionic
products, which aﬀect cellular behavior. This characteristic means
that bioglasses may have applications beyond orthopedics and be
extended to the regeneration of other tissues, such as skin and
cartilage.11 Indeed, the angiogenic capacity of bioglasses in soft
tissue is an example of this versatility.12–14
Researchers have also realized that the units of biological
tissues have nanodimensions and that communications between
cells and biomaterials occur on the nanoscale.15–17 At this level,
several interrelated properties regulate cell–biomaterial interac-
tions, such as nanotopography, surface area and energy, hydro-
philicity, and chemical composition.18,19 These features govern
contacts with proteins, modulating cell adhesion, spreading, and
proliferation; finally, they affect the long-term functionality of
implants.17,20,21 Thus, in recent decades, nanotechnology has
become a trending topic in tissue engineering; new bioactive
nanomaterials with high potential for application are being
developed and widely exploited.23
Nature has been inspiring scientists and engineers to mimic
its highly functional biopolymeric systems.25 In this regard,
naturally derived polymers have been applied in biomedicine
due to their biocompatibility, sustainability, and environment-
friendly chemistry.28 Currently, rapid technological advances
are permitting the combination of nanoscale bioactive glasses
with natural polymers, allowing the design and build of various
nanostructured biocomposites for biomedical purposes. These
applications include tissue-engineered scaﬀolds, site-specific drug
delivery systems, non-viral gene carriers, biosensors, screening,
and clinical diagnostics systems.
This review will describe the main features of bioactive glass
nanoparticles and provide a brief description of their methods
of production. Further, we will focus on nanocomposites con-
stituted from natural polymers and bioactive glass nanoparticles,
addressing the state-of-the-art technologies and their applica-
tions. A final summary prospecting the areas of future research
will also be provided.
Bioactive glass nanoparticles
Bioactive glass nanoparticles (BGNPs) are usually composed of
silicates or phosphosilicates combined with distinct proportions
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of glass modifiers, such as sodium oxide (Na2O) and calcium
oxide (CaO). As bioactive glasses, they show high bioactivity and
excellent bone bonding properties. The conventional compositions
are binary, ternary, or quaternary systems, such as SiO2–CaO,
SiO2–CaO–P2O5, and SiO2–CaO–P2O5–Na2O, respectively.
29,30
Production methods
BGNPs can be produced by various techniques, such as micro-
emulsion, flame synthesis, and sol–gel.31 A summary of the
compositions and sizes of BGNPs produced by various methods
are present in Table 1.
Flame spray. In this process, a nozzle forms an oxygen spray
that disperses the metal–organic precursors present in a liquid
mixture.2,31–33 The spray is ignited; as it burns at temperatures
above 1000 1C, the organic constituents of the liquid precursor
combust to water and carbon dioxide while the metal constituents
oxidize to form the nanoparticles. The gas-phase synthesis
method forms molecular nuclei followed by condensation and
coalescence, inducing the growth of nanoparticles in high-
temperature regions during the process.2,31–33 The main factor
affecting particle size is the mean residence time of the particles in
the high-temperature regions. High cooling rates (41000 K s!1)
and residence times ("1 ms) enable the formation of nano-
particles (Fig. 1A). The process can produce various nano-
particles with distinct compositions and with high chemical
homogeneity.2,31–33
Microemulsion. In water-in-oil microemulsions, the hydro-
carbon phase scatters nanosized water droplets, usually between
5 and 20 nm, which become surrounded by a monolayer of
surfactant molecules. These aqueous droplets act as minuscule
reactors where reactions take place when droplets containing the
reactants collide. An example of this method is the formation of
precursor particles of hydroxide or oxalate in a microemulsion
system. The desired oxide system is then developed after drying
Table 1 Composition and size of BGNPs produced by diﬀerent techniques
Technique Configuration Size (nm) Composition (wt%)
Sol–gel SiO2–CaO 40 70 : 30
40
50–90 75 : 2584
100 70 : 3036
SiO2–CaO 300 70 : 30
29
SiO2–CaO–P2O5 24 62.1 : 28.5 : 9.2
85
30 58 : 33 : 911
30 80 : 15 : 511
50 70 : 25 : 572
50 64 : 31 : 572
70 6.3 : 71 : 22.759
87 60 : 36 : 486
75–37 45 : 40 : 555
10–100 58 : 33 : 954
30–100 66 : 27 : 738
100 58 : 35 : 787
100 62 : 30 : 988
100 79 : 19 : 248
100 35.4 : 57.4 : 7.287
100 62.2 : 28.5 : 9.288
300 60 : 36 : 429
500 58 : 33 : 953
SiO2–CaO–P2O5–Ag2O 79 50 : 35 : 5 : 10
73
100 56 : 30 : 3 : 1089
100 58 : 23 : 9 : 1074
SiO2–CaO–P2O5–CuO 87 50 : 35 : 5 : 10
73
SiO2–CaO–P2O5–MgO 30–60 64 : 26 : 5 : 5
90
SiO2–CaO–P2O5–Na2O 100 45 : 24.5 : 24.5 : 6
91
SiO2–CaO–P2O5–Na2O 300 46.1 : 26.9 : 2.6 : 42.4
29
SiO2–CaO–P2O5–SrO 50 55 : 30 : 5 : 10
92
SiO2–CaO–P2O5–TiO2 50 55 : 35 : 9 : 1
76
SiO2–CaO–SrO 80–100 84 : 5 : 11
93
SiO2–CaO–ZnO 80–90 85 : 10 : 5
79
Flame SiO2–CaO–Na2O 20–80 74.3 : 11.8 : 14
2
SiO2–CaO–Na2O–B2O3 20–80 58.7 : 20.4 : 12.8 : 8.1
2
SiO2–CaO–P2O5 20–80 79.9 : 16.8 : 3.2
2
SiO2–CaO–P2O5–Na2O 20–50 44.7 : 27.6 : 4.9 : 22.8
49
20–60 44 : 24.5 : 24.5 : 794
20–80 47.8 : 25.1 : 22.6 : 4.62
SiO2–CaO–P2O5–Na2O–K2O–MgO 30 53 : 20 : 4 : 6 : 12 : 5
81
SiO2–CaO–P2O5–Na2O–K2O–MgO–SrO 30 53 : 15 : 4 : 6 : 12 : 5 : 5
81
SiO2–CaO–P2O5–Na2O–F 20–80 45.4 : 26.6 : 4.3 : 21.4 : 2.4
2
Microemulsion SiO2–CaO–P2O5 10–40 60 : 36 : 4
7
SiO2–CaO–P2O5 100 21 : 60 : 19
95
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and calcination of the precursor powder at a defined tempera-
ture (Fig. 1B). Microemulsion techniques can achieve nanoscale
particles with low agglomeration. However, the main disadvan-
tages of the microemulsion technique are the production yield
and the use of large amounts of oil and surfactants.7
Sol–gel. The common sol–gel technique for BGNP produc-
tion is an adapted procedure of the Sto¨ber method.34 In this
approach, the glass compositional precursors are first hydro-
lyzed to a sol under acidic conditions and then condensed and
precipitated to gel particles in alkaline solution. A common
silicate precursor is tetraethylorthosilicate (TEOS), while the
calcium precursors are calcium nitrate or calcium chloride and
the phosphate precursors are triethylphosphate or diammonium
hydrogen phosphate. Briefly, the procedure starts with hydro-
lysis of TEOS in water or a water/alcohol acidic mixture (creating
Si–OH groups). Then, the addition of a base (usually ammonia)
allows condensation through the release of water molecules and
the formation of Si–O–Si bonds, forming a colloidal sol. In this
stage, calcium acts as a modifier as it is ionically bonded to the
silicon via non-bridging oxygen bonds (Si–O–Ca). Also, when
phosphorus is incorporated into the BGNP formulation, it
forms orthophosphates, which are charge balanced by calcium
ions.35,36 The primary nanoparticles present in the sol coalesce
and bond together, forming a silica-based gel network of assembled
nanoparticles. This gelation step continues from minutes to
a few hours after adding pre-hydrolyzed TEOS to the basic
solution. A further drying step is used to remove excess water
and prevent secondary aggregation of the gel particles by linkage
with water molecules. The gel network is broken by calcination
at a temperature above 680 1C. This process also stabilizes the
incorporation of calcium and phosphorous (when applicable)
and removes nitrates and organic phases. Finally, BGNPs are
obtained (Fig. 1C). Experimental conditions such as pH, solvent
volumes, reagent ratios and surfactants can be changed.
This milieu influences the processes of hydrolysis and conden-
sation and determines the chemical composition, agglomeration,
and size of the BGNPs. Also, the synthesis and calcination tem-
perature has an important effect on the crystallization process of
BGNPs. The sol–gel route allows easier control of the chemical
composition, morphology, size, and structure.9,13,37–43 In a
variation of the method, Liang et al. synthesized two types of
mesoporous BGNPs using a sacrificial liquid template by a
sol–gel method. They produced spherical nanoparticles with
radial mesoporous and pineal nanoparticles with lamellar
mesopores.44 With this methodology, the size and structure
of the nanoparticles could be tuned by the reaction conditions.
Lei et al. also developed BGNPs with controllable sizes and
morphologies by combining an acid-catalyzed sol–gel process and
gelation-induced phase separation technology.45 These findings
demonstrate the effects of BGNP production methods on their
physicochemical and biological properties.
Physiochemical properties and biological implications
Size and surface area. Particle size and surface area play a
significant role in the interaction of materials with cells. As
mentioned, nanomaterials have a high surface area to volume
ratio.46 For example, Gerhardt et al. described microsized
Bioglasss with a median particle size of 4.3 mm and a specific
surface area of 2.7 m2 g!1; nanoscaled Bioglasss, with diameters
of 35 to 40 nm, presented a specific surface area of 79 m2 g!1.47
This feature confers a higher surface energy and surface reac-
tivity to nanoscale bioactive glasses when compared with their
microscale counterparts. Thus, a nanoscale bioactive glass holds
a faster ion release rate and an increased surface area for protein
adsorption. As a result, these nanoparticles can promote cell
adhesion, proliferation, and diﬀerentiation.21,48–51 The size of
bioactive glasses has shown to affect their in vitro osteogenic
capacity.52,53 Caridade et al. also found that Bioglasss nano-
particles induced early precipitation of apatite in SBF compared
with microsized Bioglasss.52,53 In fact, compared with micro-
sized particles, Bioglasss glass nanoparticles promoted higher
adhesion of human osteoblast-like cells (MG-63) and induced an
early and superior osteogenic gene expression of alkaline phos-
phatase (ALP), runt-related transcription factor two (RUNX2) and
collagen I (COL1).53 Gong et al. reported similar results with a
distinct composition of the nanoscale bioactive glass.54 The
authors found that the ionic dissolution of BGNPs improved
cell proliferation and activation of osteogenic genes when com-
pared with micro bioactive glasses.54 These studies showed that
BGNPs have a higher ability for apatite formation and stronger
osteogenic ability compared with microscale bioactive glasses.
Even inside the nanolimits, distinct sizes lead to distinct results.
Ajita et al. compared three sizes of nano bioactive glasses
(approx. 74.7 nm, 43.25 nm, and 37 nm) in mouse mesenchymal
stem cell behavior.55 They showed that all the BGNPs were non-
cytotoxic at 20 mg mL!1 but noted increased proliferation in
cells treated with the smallest nanoparticles.55 Additionally, the
dissolution rates of ions varied according to the size of the
nanoparticles. Also, the particles with smaller sizes triggered
lasting activation of extracellular regulated kinases and
Fig. 1 Morphologies of BGNPs produced by diﬀerent methods. (A) TEM
image of a flame-made BGNP sample showing a high degree of agglo-
meration (SiO2–CaO–P2O5–Na2O). (B) SEM images of BGNPs generated
by microemulsion (SiO2–CaO–P2O5). (C) TEM micrograph of BGNPs pro-
duced by the sol–gel process (SiO2–CaO–P2O5). Adapted from ref. 2,
7 and 9, respectively.
Journal of Materials Chemistry B Review
4558 | J. Mater. Chem. B, 2017, 5, 4555--4568 This journal is©The Royal Society of Chemistry 2017
upregulation of cyclin genes that modulate the cell cycle from
the G0/G1 phase to the S and G2/M phases.55 This study high-
lighted the dependency of the cell proliferative action on nano-
sized particles.
Morphology. It is also important to understand the relation-
ship between the size and shape of particles to develop eﬀective
nanomaterials. The majority of the produced BGNPs presented
spherical shapes. Indeed, it has been reported that endocytosis
of spherical nanoparticles is easier and faster compared to that
of rod-shaped or fiber like nanoparticles.56,57 However, non-
spherical nanoparticles may be advantageous in certain appli-
cations. These nanoparticles can be combined with natural
polymers to design bioactive biomaterials with improved
mechanical properties.58 In this regard, Hong et al. synthesized
rice-shaped BGNPs.59 In vitro bioactivity tests showed that these
novel bioactive nanoparticles have excellent biomineralization
capability.59 Other studies also reported the production of
BGNPs with distinctive shapes that ranged from pineal and
spherical to short and long rods.44,60 This shapes may be bio-
logically advantageous in biomaterials, as natural bonematerials
contain micro/nanoscale needles or rod-like hydroxyapatite
structural units.61
Surface properties. The surface of BGNPs largely defines
their performance in biological systems. Various aspects, such as
selective protein adsorption and transmembrane permeability,
are regulated by the surface of nanoparticles. Surface charge is
a determinant in the aggregation of nanoparticles. Bearing this
in mind, Chen et al. improved the dispersibility of BGNPs by
coupling a silane agent onto the surface of the nanoparticles.
The results indicated that –NH2 groups appeared on the surface
of the modified BGNPs, proving that the groups of the silane
agent were covalently bonded to the surface of the BGNPs.62
In another study, Lee et al. investigated the uptake efficiency of
amine-functionalized BGNPs and their role in odontogenic
differentiation.63 BGNPs were fabricated by sol–gel synthesis, and
a silane agent was used for surface functionalization, changing
the charge of the nanoparticles from negative to positive. The
uptake of amine-functionalized BGNPs in rat dental pulp stem
cells was determined to be about 92% after 4 hours of incu-
bation. The results also indicated that amine-functionalized
BGNPs induce odontogenic differentiation, as the expression of
odontogenic-related genes (BSP, COL1A, DMP-1, DSPP, and
OCN) and the capacity for biomineralization were significantly
upregulated.63
Porosity. Factors such as porosity can empower the function
of nanoparticles. Indeed, development of porous BGNPs for
drug delivery applications is increasing.64 The porosity, pore
size, and pore shape of BGNPs can be controlled by tuning the
previously described production methods through the use of
templates (i.e. CTAB and CPB).44,65 The resulting porous or
hollow structures of BGNPs can provide larger specific surface
areas and voids, which may be useful as containers for drug
delivery applications.66 In this regard, Kim et al. studied the
potential of BGNPs for gene delivery of mesenchymal stem cells
(MSCs).67 The BGNPs were designed with enlarged pore sizes
to eﬃciently load and deliver bone morphogenetic protein-2
(BMP2) and plasmid DNA (BMP2–pDNA). Moreover, the BGNPs
were efficient in the loading and in the sustained release of
BMP2–pDNA. The BMP2–pDNA/BGNPs complexes were inter-
nalized in MSCs, and the majority of cells were transfected to
express the BMP2 protein.67
Composition. The chemical nature of BGNPs also contributes
to the role of the nanoparticles. Indeed, the porous structure and
surface area of the BGNPs were shown to be dependent on their
composition.68 In this regard, the composition of BGNPs aﬀects
the ability of the material to support the proliferation and
function of cells.69–71 Moorthi et al. synthesized ternary BGNPs
(SiO2–CaO–P2O5) with different amounts of calcium oxide and
silica (70 : 25 : 5 and 64 : 31 : 5 mol%) and studied their role in
osteoblast proliferation.72 Both BGNPs were non-cytotoxic to
MG-63 cells; however, the formulation with higher calcium
content was more effective in osteoblast proliferation and pro-
moted cell proliferation, with more cells entering into G2/M cell
cycle phases. Also, they observed a clear expression of cyclin
proteins.72 These results suggest that adapting the ionic consti-
tuents of BGNPs can lead to distinct biological properties. It is
estimated that the controlled release of ions from bioactive
glasses can stimulate interactions with tissues, such as new bone
growth.69 The rate of ion release depends primarily on the
composition, particle size and surface area, which affect osteo-
genesis and angiogenesis. In this regard, BGNPs became a
vehicle for the local delivery of specific ions to control cellular
functions. Ion-doped BGNPs are being designed for the con-
trolled release of specific metal ions, which can increase osteo-
blast activity (for example, in strontium doped-BGNPs) or have
valuable anti-inflammatory effects (for example, in zinc-doped
BGNPs). Copper-doped BGNPs (SiO2–CaO–P2O5–CuO) and silver-
doped BGNPs (SiO2–CaO–P2O5–Ag2O) have antibacterial proper-
ties, preventing bacterial colonization.73–75 Goh et al. described
the ion release profiles of these BGNPs. The authors noted a
faster release of Ag, which made silver-doped BGNPs a rapid
bacteria-killing agent. Meanwhile, because of their slower
release, copper-doped BGNPs may be suitable candidates for
long-term antibacterial protection.73 Copper-doped BGNPs have
also been synthesized to decrease or inhibit the growth of
pathogens. The authors concluded that the nanoparticles
showed bioactive behavior with antimicrobial activity against
Staphylococcus aureus as the copper content increased.75 Also,
titanium dioxide can be a powerful antibacterial substance, as
TiO2 shows high oxidizing power under irradiation with UV
light. Therefore, Rajendran et al. prepared titanium-doped BGNPs
(SiO2–CaO–P2O5–TiO2).
76 They reported antibacterial effects against
Escherichia coli and Staphylococcus aureus. Additionally, cyto-
toxicity tests showed that the nanoparticles were non-cytotoxic
and showed improved cell viability in MG-63 cells at a concen-
tration of 125 mg mL!1.76 These particles could thus reduce
bacterial infections in biomaterial implants. Zinc-doped BGNPs
(SiO2–CaO–ZnO) were shown to promote odontogenic differ-
entiation and angiogenesis. The zinc ion is an essential trace
element in bone and is considered for use in osteoporosis treat-
ments.77,78 Zhang et al. tested zinc-doped BGNPs on human
dental pulp cells.79 The zinc-doped BGNPs increased ALP activity,
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improved the formation of mineralized nodules, and upregulated
mRNA expression of odontogenic differentiation marker genes in
a time and dose-dependent manner.79 Strontium-doped BGNPs
showed favorable effects on osteogenic stimulation and bone
formation. In this regard, Strobel et al. assessed the osteogenic
potential of BGNPs containing strontium (SiO2–CaO–P2O5–
Na2O–K2O–MgO–SrO) on human bone marrow stromal cells
(hBMSCs).80 Cell growth and morphology studies showed the
high cytocompatibility of the nanoparticulate bioactive glass.
Moreover, the strontium-doped particles improved the expres-
sion of osteocalcin, collagen type I and vascular endothelial
growth factor.80 However, is also important to notice that
increasing their strontium content can delay the bioactive
behavior of BGNPs because of the inhibitory effect of strontium
on apatite mineralization.81 Xue et al. synthesized monodispersed
europium (Eu)-doped BGNPs with a dual function of bioactivity
and luminescence by a template-assisted sol–gel method. The
fluorescence was achieved by doping Eu into the BGNP network,
which did not decrease their biomineralization potential. The
nanoparticles also demonstrated cellular biocompatibility by
enhancing the proliferation and metabolic activity of osteoblast
cells. Also, BGN–Eu was successfully used to label a mouse
osteoblastic cell line (MC3T3) by strong red fluorescence with
low background noise.82
Nanoparticle safety
The safety of nanoscale particles is an issue of concern. Although
studies have shown that nanoscale bioactive glass show equal
performance compared to commercial micropowder bioactive
glasses, this topic will also be considered in this review.
Despite the acceptable non-cytotoxicity and non-genotoxicity
of BGNPs, concerns have arisen about their internalization
from cells and the resulting long-term body biodistribution.
It is known that a localized increase in intracellular silica and
calcium concentrations can have a marked eﬀect on cell meta-
bolism or inflammatory response. Another concern is that if the
particles dissolve intracellularly, they may also break up into
finer particles that can escape the endosomal pathway and
enter the cell cytoplasm or even the nucleus. In this regard,
studies have addressed the issue by studying the response
of MSCs and adipose tissue-derived stem cells (ADSCs) to
BGNPs.42,83 The results confirmed cellular uptake and localiza-
tion of the nanoparticles in the cell cytoplasm and cell endo-
somes and partial particle dissolution inside the cells. It was
hypothesized that the dispersion of particles, combined with a
finer control of their size, dramatically increased the number of
particles taken up by the cells. However, the uptake mechanism
remained unclear.
More importantly, the particles were non-cytotoxic at lower
concentrations and had slight eﬀects on the viability of primary
MSCs and ADSCs at higher concentrations (100 and 200 mgmL!1).
Also, BGNPs had negligible eﬀects on cell proliferation compared
with the control.
These slight eﬀects on cell metabolism and proliferation
combined with the large numbers of particles detected inside
the cells showed acceptable safety. Also, these results pave the
way for the use of BGNPs as injectable target particles to be
internalized by cells for the continuous local delivery of inorganic
therapeutic ions.42,83
Nanocomposites
The development of composite materials is an attractive field
in tissue engineering. The favorable properties of two or more
types of materials can be combined to tailor the response of a
biomaterial to the mechanical and physiological demands of
the host tissue.
Specifically, in bone tissue engineering, the bioactivity of a
biomaterial is an important feature. However, several attractive
biomaterials are not intrinsically bioactive.96 A strategy to provoke
desirable bioactive behavior is the inclusion of nanoscale bio-
active glasses in the polymer matrix, creating a composite
material. The volume fraction of nanoscale bioactive glasses can
adjust the bioactivity of the resulting composite while retaining
the properties of the polymer, such as the ability to deform under
loads.97,98 This combination has already been used to create
nanocomposite materials for orthopedic implants, bone filler
materials, injectable bonematerials, 3D biocompatible scaﬀolds,
and membranes (Fig. 2).9,97–101
Despite their bioactive benefits, other general properties should
be noted when polymer matrices incorporate BGNPs.
Mechanical properties
It is known that nanoscale bioactive glasses can cause signifi-
cant improvements in the mechanical properties of composite
scaﬀolds, namely their elastic moduli and, for strong interfacial
bonding, their tensile compressive strengths.9,18,70,96,102–104
Furthermore, this feature results in a synergistic gain.
In one way, combination with polymers overcomes the lack of
cohesive strength of the particulate BGNPs and prevents their
possible displacement and migration under externally applied
forces during the healing period.105 Therefore, BGNPs are incor-
porated within polymeric systems, where the polymer acts as a
continuous medium for immobilization of the particles.
In another way, the nanosize of BGNPs strengthens the poly-
mers. As previously stated, because of the greater specific surface
area, the nanofiller will enable higher contact eﬀects. This feature
results in improved mechanical properties of the materials
when compared with micrometer-structured composites.52 Also,
strategies to prevent the agglomeration of the nanoscale reinforce-
ments enable fine homogeneous dispersion of the nanofillers
in the polymer matrix, which also contributes to strengthened
mechanical properties.9,100,106
Degradation properties
The addition of nanoscale bioactive glasses to bioresorbable
polymers can alter the polymer degradation rate. This outcome
occurs because of the rapid exchange of protons in water for the
alkali elements of the bioactive glass. The resulting change in
the surface and bulk properties of the composites increases the
hydrophilicity and water absorption of the polymer matrix,
Journal of Materials Chemistry B Review
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which alters the scaﬀold degradation kinetics.102,107 Also, bio-
active glasses can produce an alkaline environment.108 Thus,
when a composite incorporates BGNPs, this increase in pH can
prevent the acidic degradation of some polymers. However, this
alkalization can also aﬀect the functionality of the composite.
For instance, studies on dental applications showed that the
increase in pH caused by BGNPs could buﬀer the acidity induced
by polymeric scaﬀolds, which contributed to lower antimicrobial
activity and thus canceled its therapeutic eﬀects.109 It can be
assumed that even if occasionally useful, the buﬀering eﬀect of
BGNPs in this dental application was deleterious to its final
application.
This finding clearly showed that the biomaterial design must
be adapted to the targeted role.
Biological properties
Regarding their biological properties, BGNPs can create nano-
structured features in composites as nanotopographies on the
scaﬀold surface. This characteristic may increase contact eﬀects,
which can also contribute to improved bioactivity.110
Thus, incorporating nanoparticles in biopolymers can
modulate protein absorption. This surface tailoring may improve
cell attachment and the resulting cell behavior.96 In fact, the
higher surface area increases the interactions between the surface
of an implant and its biological environment.111
Also, in bone applications, the insertion of nanoparticles into
a polymeric matrix is thought to mimic the nanocomposite-like
bone structure. Webster et al. have reported a significant
increase in protein adsorption and osteoblast adhesion on
nanoscale ceramic materials compared withmicron-sized ceramic
materials.112 Also, mimicking the nanoscale features of bone
at the surface of synthetic bone implants has been shown to
increase cell adhesion, proliferation, and bone formation.51
Also, the extracellular matrix (ECM), which surrounds cells in their
natural environment, is a nano-organized structure formed by bio-
molecules configured in distinct geometric arrangements.113,114
Natural polymers in nanocomposites
Naturally derived polymers have been widely proposed for use in
tissue regeneration because they are similar to macromolecules
present in the biological environment and produce degradation
products that can be recognized and metabolized by the body.28
A summary of nanocomposite constructs based on BGNPs and
natural polymers is provided in Table 2.
Alginate
Alginate is a natural polysaccharide obtained from brown
seaweeds that form stable hydrogels in the presence of divalent
cations. It is hydrophilic, biocompatible, and inexpensive
and is commonly employed in the food and pharmaceutical
industries.115,116
Srinivasan et al. tested the impact of BGNPs on alginate for
periodontal tissue regeneration by producing composite scaf-
folds by freeze-drying (Fig. 3A).1 The results showed reduced
swelling, which may be due to the strong binding between
alginate and BGNPs and to the decrease in pore size. Also, the
exposed BGNPs on the scaﬀold surfaces increased the binding
sites on the surface, which may be responsible for the improved
biomineralization and protein adsorption observed by the
authors. Additionally, BGNPs encouraged the attachment and
proliferation of human periodontal ligament fibroblast (hPDLF)
and MG-63 cells. This eﬀect was also ascribed to the increases in
surface area and surface roughness because of the incorporation
of BGNPs. The presence of BGNPs improved the ALP activity of
hPDLF cells with a ceiling of seven days because of the release of
Fig. 2 Naturally derived nanocomposites: from the production of bioactive glass nanoparticles to their biomedical applications.
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ions and dissolution products from the bioactive glass accom-
panied by a subsequent decline of this expression. The decrease
after seven days can be assigned to the culmination of osteo-
blastic diﬀerentiation.1 Therefore, the results indicate that these
biocompatible composite scaﬀolds could be advantageous for
periodontal tissue regeneration.
Several researchers developed nanocomposite films and
scaﬀolds which combined alginate with BGNPs and were cross-
linked with Cu2+, Ca2+, and Ga3+ for bone tissue engineering.117–120
The incorporation of BGNPs into alginate significantly improved
the tensile strength of the nanocomposites.117–119 Biominerali-
zation studies indicated the deposition of apatite on the surface
of the films, suggesting their bioactive behavior as a con-
sequence of the added BGNPs.117–119 The in vitro results
indicated that the bioactive ions released from both nanocom-
posite biomaterials stimulated the differentiation of rat bone
marrow-derived mesenchymal stem cells (rBMSCs) towards
the osteogenic lineage.118 The typical endothelial cell property
of forming tubes in Matrigel was observed for human umbilical
vein endothelial cells (HUVECs) when in contact with the
biomaterials, which indicates their angiogenic properties.118
Ga–alginate films containing BGNPs induced a bacteriostatic
effect in vitro towards S. aureus due to the presence of
Ga3+ ions.119
Chitin
Chitin is a harmless and biodegradable polymer that is struc-
turally analogous to the ECM of many physiological tissues.
Due to these features, chitin is an interesting material to con-
sider for several biomedical applications.121,122 The lack of
solubility of chitin in most solvents is a challenge to the use
of polysaccharide in the fabrication of devices. However, it is
possible to fabricate nanocomposite scaﬀolds that combine
chitin with BGNPs by a freeze-drying procedure (Fig. 3B).4,123
Chitin was first added to a mixture of CaCl2#2H2O/methanol
and mixed until a clear solution was achieved. Then, the undis-
solved chitin was separated by filtration and dialyzed to extract
the calcium ions. The chitin hydrogel was blended with BGNPs
and freeze-dried to obtain the composite scaﬀolds. The result-
ing scaﬀolds showed a homogeneous dispersion of BGNPs on
their porous surfaces. Further, the scaﬀolds showed increased
swelling, bioactivity, and degradation compared to the control
scaﬀolds without BGNPs. The composite scaﬀolds were non-
toxic to MG-63 and human primary osteoblast (hPOB) cells
and sustained cell attachment, spreading, and proliferation.
Mineralized bone nodules and calcium precipitates also formed,
showing strong mineralization of the hPOB cells. The develop-
ment and mineralization of the hPOB cells without osteogenic
Table 2 Summary of polymeric nanocomposites based on bioactive glass nanoparticles and natural polymers
Polymer(s) BGNPs Structure Production technique Applications
Alginate SiO2–CaO–P2O5 Scaﬀold Freeze drying Periodontal tissue regeneration
1
Alginate/gelatin SiO2–CaO–P2O5–Na2O Films Casting Bone tissue engineering
141
Alginate dialdehyde–gelatin SiO2–CaO–P2O5 Construct Bioplotting Bone tissue engineering
92
Chitin SiO2–CaO–P2O5 Scaﬀold Freeze drying Bone tissue engineering
4
Chitosan SiO2–CaO Membrane Solvent casting Guided tissue regeneration
40,99
SiO2–CaO–P2O5 Films Layer by layer Coatings of orthopedic implants
142
Hydrogel Mixing Bone tissue engineering5
Mixing Injectable systems101
Membrane Solvent casting Guided tissue regeneration127
Stamping Patterned medical membranes128
Scaﬀold Freeze drying Bone tissue engineering132
SiO2–CaO–P2O5–MgO Membrane Solvent casting Bone tissue engineering
90
Chitosan/hyaluronic acid SiO2–CaO–P2O5 Films Layer by layer Coatings of orthopedic implants
143
Membrane Layer by layer Guided tissue regeneration144
SiO2–CaO–P2O5–Ag2O Films Layer by layer Antibacterial coatings for
orthopedic implants89
Collagen SiO2–CaO–P2O5 Membrane Electrospinning Bone regeneration
145




SiO2–CaO–P2O5 Scaﬀold Freeze drying Bone tissue engineering
27,146
Gelatin SiO2–CaO–P2O5 Scaﬀold Freeze drying Nerve regeneration
22
Bone tissue engineering implants137
Gelatin/chitosan SiO2–CaO–P2O5 Scaﬀold Freeze drying Alveolar bone regeneration
140
Gelatin/collagen SiO2–CaO–P2O5–Na2O Scaﬀold Freeze drying Myocardial regeneration
147
Gellan gum SiO2–CaO Scaﬀold Freeze drying Bone tissue engineering
24
Journal of Materials Chemistry B Review
4562 | J. Mater. Chem. B, 2017, 5, 4555--4568 This journal is©The Royal Society of Chemistry 2017
supplements confirmed the desirable features of the nano-
composites.123 These nanocomposite scaﬀolds are potential
contenders for tissue engineering purposes.
Chitosan
Chitosan (CHT) is a biopolymer produced from the deacetylation
of chitin; it is soluble in aqueous acid solutions, which oﬀers
high processability.124,125 CHT is biocompatible, biodegradable
to innocuous products and non-antigenic.28,126 Therefore, CHT
has been extensively used for biomedical studies.
To improve the bioactivity and mechanical properties of
CHT-based structures, nanocomposites that combine CHT and
BGNPs are also being studied. In this regard, Couto et al.
combined a CHT–glycerophosphate salt formulation with BGNPs
to produce bioactive thermo-sensitive hydrogels.101 The system
gelled at around 36.8 1C, which is applicable for intracorporeal
purposes. The hydrogel proved to be bioactive, and the density
of the apatite deposits increased with the addition of BGNPs.
This system may be used as a thermo-sensitive hydrogel for
orthopedic rehabilitation as the nanosize of the BGNPs guaranteed
the efficient injection of the nanocomposite into bone defects
through small-gauge needles.101 A high-throughput screening
of hydrogel nanocomposites was developed to select the leading
combination that influences the pre-osteoblast response.5 The
addition of BGNPs in quantities greater than 12.5% (wt/wt of CHT)
considerably improved the storage modulus of the hydrogels.
Fig. 3 (A) Structure of alginate polymer and SEM image showing the macroporous construct of the alginate/BGNPs composite scaﬀold; adapted from
Srinivasan et al.1 (B) The structure of chitin polymer and SEM images of the macroporous structure of the composite scaﬀolds. The pore sizes ranged
from 150 to 500 mm; adapted from Peter et al.4 (C) Structure of chitosan polymer and SEM micrograph of MC3T3-E1 response after three days of cell
culture; adapted from Oliveira et al.5 (D) Fragment structure of collagen type I, where ProHypGly is the most common triplet,6 and the microstructure of
20 wt% BGNPs containing collagen film. Note the micron-sized clusters of BGNP particles (arrows); adapted from Vargas et al.10 (E) Cross-section from
the porous gelatin nanocomposite conduit; adapted from Koudehi et al.22 (F) Structure of gellan gum polymer and SEM images of the scaﬀolds with
50 wt% of BGNPs; adapted from Gantar et al.24 (G) Structure of alginate–dialdehyde polymer and figures depicting the fabricated constructs of ADA–
GEL–BGNPs in hydrated and dehydrated forms; adapted from Leite et al.26 (H) Structure of hyaluronic acid polymer and SEM micrographs of composite
scaffolds prepared from cross-linked BGNPs–COL–HYA–PS; adapted from Wang et al.27
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The elastic modulus determined for this formulation also fits
the values described for the granulation tissue occurring during
bone regeneration. Moreover, this amount of BGNPs favored
MC3T3 pre-osteoblast cell proliferation and spreading (Fig. 3C).5
CHT was also combined with distinct formulations of BGNPs,
ternary nanoparticles and magnesium-doped BGNPs, to produce
membranes for guided tissue regeneration.90,99 These mem-
branes were employed as boundaries to limit faster-growing soft
tissue cells at the injury site and to restore periodontal liga-
ments, cementum, or bone.90,99,127 These nanocomposite mem-
branes can be formed by solvent casting. The membranes
prepared with BGNP formulations presented increased stiﬀness
and showed acceptable extensibility in wet conditions without
premature degradation. Also, it was noted that the magnesium-
doped BGNPs increased the hydrophilicity of the composites
when correlated with nanocomposites filled with non-doped
BGNPs, indicating that changes in the formulation of the BGNPs
could tailor the features of the nanocomposite. Importantly,
upon immersion in SBF, the composite membranes induced
apatite deposition compared with pure CHT membranes.
Following this subject, Caridade et al. observed the biominer-
alization of CHT/BGNPs composite membranes by dynamical
mechanical analysis (DMA).52 The nanostructured membranes
showed an improvement in the Young’s modulus associated
with the onset of apatite formation. Thus, the membranes had
improved mechanical properties and higher bioactivity than
both bare CHT membranes and CHT membranes containing
bioactive glass microparticles.52 Studies with osteoblastic-like
cells (SaOs-2) revealed that the nanocomposite membranes
were non-cytotoxic. It was further observed that the addition
of BGNPs improved the proliferation andmetabolism of human
periodontal ligament cells (hPDLCs) and hBMSCs. Further,
BGNPs promoted greater cell matrix mineralization by both
types of cells.90,99,127 Also regarding membranes, Luz et al. used
a micro-imprinting strategy to create BGNP micropatterns onto
CHT membranes.128 The bioactive character of the BGNP spots
allowed restricted nucleation and growth of apatite. The results
showed that the fibroblast L929 cells mirrored the first bio-
active pattern, choosing the milieu formed by the BGNPs rather
than moving to the exposed CHT regions. With this strategy,
it was found that it is feasible to spatially control the bioactive
behavior and cellular interactions in a polymeric matrix. This
method may be employed under co-cultures or to produce sub-
strates that may confine cells in particular regions.128
In addition to hydrogels and membranes, further CHT nano-
composite scaﬀolds containing BGNPs have been built by
freeze-drying.129,130 These nanocomposites showed acceptable
swelling and degradation. In vitro studies showed apatite deposi-
tion at the surface of the nanocomposite scaﬀolds, demonstrating
their bioactive abilities. The study of the behavior of MG-63 cells
revealed that cells adhered to the pore walls of the scaﬀolds and
presented early indications of spreading. A particular aspect of
CHT scaﬀolds is their shape memory capacity. Shape memory
polymers can be distorted and locked into a temporary shape,
which remains stationary unless presented with a stimulus that
prompts the polymer to restore its primitive shape. Therefore,
spherical nanocomposite scaﬀolds were produced to combine
the shape memory properties of CHT and the biomineralization
ability of BGNPs.131,132 Adding BGNPs improved the bioactivity
of the nanocomposite scaﬀold, as perceived by the precipitation
of an apatite layer upon immersion in SBF; this demon-
strates their osteoconductive potential. Further, including BGNPs
in the CHT matrix improved the stiﬀness of the constructs.
CHT/BGNPs composites showed superior shape memory proper-
ties compared to CHT, and the scaﬀold composites presented
excellent shape memory properties, as outlined by their signifi-
cant recovery ratios and high fixity ratios. The applicability of
these structures was shown by proper geometric accommodation
of previously compressed nanocomposites in a bone deformity.
The natural shape memory behavior of these nanocomposites
revealed their potential use for minimally invasive strategies in
bone tissue therapies.131,132
Collagen
The application of collagen-based biomaterials in regenerative
medicine has been growing intensely over the past few decades.
Collagen plays a vital function in the organization of tissues and
organs and assists in functional expressions of cells. Notably,
type I collagen is the principal organic component of the bone
matrix and is one of the most commonly used biomaterials.133
The angiogenic capacity of collagen nanocomposites contain-
ing BGNPs using the quail chorioallantoic membrane (CAM) was
examined as a substitute for the classical mammalian models of
angiogenesis (Fig. 3D).10 Interestingly, at 24 h post-implantation,
collagen films with 10 wt% of BGNPs stimulated angiogenesis
by expanding the fraction of blood vessel branch points by
40%. In contrast, nanocomposite films containing 20 wt%
BGNPs were found to suppress angiogenesis. This exploratory
investigation revealed that supplementing a particular concen-
tration of BGNPs in collagen films leads to an early angiogenic
response.10
To circumvent the poor mechanical properties of collagen
hydrogels in hard tissue engineering, El-Fiqi et al. developed
nanocomposite hydrogels made of collagen and BGNPs func-
tionalized with amine groups on their surfaces. The amine-
functionalized BGNPs facilitated chemical bonding with amino
acid sequences of the collagen molecules. Thus, the nano-
composite hydrogels exhibited improved physicochemical and
mechanical stability due to physical crosslinking. Moreover, the
hydrolytic and enzymatic degradation of the nanocomposite
was diminished. MSCs cultivated within the nanocomposite
hydrogels remained viable, with enhanced cytoskeletal extensions.
Moreover, the addition of amine-functionalized BGNPs resulted
in no noticeable shrinkage over 21 days.134
Gelatin
Due to concerns about the antigenicity associated with collagen,
gelatin has attracted the attention of researchers.135 Gelatin is a
denatured protein that is extracted by hydrolysis of animal
collagen; it has been widely used in foods, cosmetics, pharma-
ceutics, and medicine as wound dressings, as adhesives and
absorbents for surgical use.136
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In this regard, Koudehi et al. designed a BGNPs/gelatin
conduit for peripheral nerve regeneration (Fig. 3E).22 The
guidance channel was examined in the right sciatic nerve of a
male Wistar rat. Twenty rats were randomly divided into two
experimental groups, one with the nanocomposite and the
other comprising normal rats. The results showed that after
three months, nerve regeneration of the nanocomposite group
was statistically equivalent to the standard group. These results
suggested that the nanocomposite could be suitable as a bio-
compatible and biodegradable candidate for peripheral nerve
repair. The bone regeneration ability of the BGNPs/gelatin
scaﬀold was also tested in a bone critical-sized defect.137 The
radiographic evaluation showed that the nanocomposite scaf-
folds could successfully bridge the critical-sized defect. X-ray
analysis also revealed that bioactive glass scaﬀolds supported
healthy bone formation by intramembranous formation. This
study presents the development of nanocomposite scaﬀolds
that contribute significantly to growth and healing of bone.137
Johari et al. evaluated the biocompatibility and regenerative
properties of BGNPs in a gelatin scaﬀold by animal implanta-
tion using a rat model.138 They showed that the nanocomposite
was cell-compatible, as it allowed osteoblasts to adhere, spread
and proliferate. The in vivo results indicated that the nanocom-
posite contributed to bone regeneration and was biodegradable
and biocompatible. Moreover, the seeded scaﬀolds with osteo-
blasts enhanced the repair of critical bone defects.138
Wang et al. also combined BGNPs of diﬀerent sizes with
gelatin, forming nanocomposite scaﬀolds for artificial bone
grafting.139 They found that the mechanical properties of the
nanocomposite scaﬀolds couldmatch those of natural cancellous
bones. Additionally, the size of BGNPs has been shown to have a
substantial impact on the mechanical properties of nanoparticle–
gelatin composite scaffolds. As the size of the BGNPs decreased,
both the modulus and strength were found to increase, which
probably resulted from the increasing interfacial area between
the nanoparticles and the gelatin. This effect was also attributed
to the homogeneous dispersion of the nanoparticles inside the
polymer matrix and the active interactions between the particles
and gelatin due to the surface silanol groups present on the
surface of the nanoparticles. The bioactivity was also found to
increase with decreasing BGNP size. Furthermore, the incorpora-
tion of BGNPs endowed the nanocomposite scaffolds with bio-
activity, thus stimulating the attachment, growth, and proliferation
of preosteoblasts.139
Gellan gum
Composites have been developed to demonstrate the possibility
of enhancing the mechanical properties and the bioactivity
of gellan gum using BGNPs (Fig. 3F).24 Although the BGNPs
agglomerated within the gellan gum matrix, they significantly
improved the microstructure of the original gellan gum hydro-
gels as they increased the roughness of the pore walls, which
may help cell attachment. Although the Young’s modulus and
the point of failure occurred at higher loads when gellan gum
was reinforced, their mechanical properties were below the
values for load-bearing applications. However, refinement of
the mechanical properties could be achieved by a fine disper-
sion of the nanoparticles in the polymer matrix. Nevertheless,
by including the BGNPs, the composite material could form
an apatite layer when immersed in SBF. Further, the ADSCs
remained viable and could adhere and spread within the pro-
duced sponge-like nanocomposite, which is a meaningful out-
come regarding their application in bone tissue engineering.24
Gelatin/chitosan
Peter et al. introduced ternary BGNPs into a gelatin–CHTmatrix
which formed porous composite scaffolds upon freeze-drying.140
They noted that the addition of BGNPs decreased the degrada-
tion and swelling ability of the scaffolds and increased protein
adsorption. Biomineralization studies showed a higher number
of mineral deposits on the nanocomposite scaffold, which
increased with incubation time in SBF. Cell studies with human
osteosarcoma cell line (MG-63) cells revealed that the composite
scaffolds with BGNPs favored cell attachment and spreading.
Therefore, the developed nanocomposite scaffold is a potential
candidate for periodontal/alveolar bone tissue applications.140
Alginate dialdehyde/gelatin
The combination of gelatin and alginate dialdehyde (ADA–GEL)
aims to overcome the limits of alginate, such as low viscosity and
dissolution in physiological media. Most importantly, alginate
discourages cell interactions that are essential features in tissue
engineering. Therefore, ADA–GEL has been shown to support
cell adhesion and proliferation.
Rottensteiner et al. combined ADA–GEL with quaternary
BGNPs to produce hydrogel films by solvent casting.141 In vivo
implantation did not show a significant immune reaction and
showed degradation of the films after four weeks, which would
ideally address the onset of bone formation. Moreover, con-
tinuing vascularization could be detected after four weeks.
However, no difference was noted between the composite and
the pure ADA–GEL.141
In other work, ADA–GEL constructs incorporating BGNPs
were produced by biofabrication to obtain a grid-like nanocom-
posite for bone tissue engineering purposes (Fig. 3G).26 The
BGNPs were synthesized from a sol–gel route and doped with
strontium. This nanocomposite hydrogel successfully induced
the formation of an apatite bone-like layer on its surface and
could sustainably release a drug model. The biofabrication pro-
cess allowed the incorporation of MG-63 cells into the com-
posite material. Cells were homogeneously distributed within
the hydrogel composite, and no difference was found in cell
viability between plain ADA–GEL and the nanocomposite con-
structs, proving that the addition of BGNPs did not influence
cell fate.26
These studies show that the addition of BGNPs may contribute
to the bioactivity of ADA–GEL while preserving its advantages.
Gelatin/hyaluronic acid
Gelatin has been used to increase the flexibility of biomaterials;
however, it has poor mechanical properties, particularly inade-
quate wet tensile strength. This feature is important because
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gelatin or collagen devices are often designed to provide space-
filling functions in aqueous environments.
In this regard, Zhou et al. studied the influence of BGNP
content on the physicochemical and biological properties of
Gel–HA/BGNPs composite scaffolds fabricated by freeze-drying. The
authors could control the porosity and swelling by adjusting the
BGNP content. Moreover, the addition of BGNPs strengthened
the material and enhanced the viability and ALP activity of
fibroblasts.
Collagen, hyaluronic acid, and phosphatidylserine
Wang et al. produced a novel porous bioactive nanocomposite
composed of sol–gel-derived BGNPs, collagen, hyaluronic acid,
and phosphatidylserine (BGNPs–COL–HYA–PS) by freeze-drying
(Fig. 3H).27 They further synthesized a cross-linked bioactive
nanocomposite using 1-ethyl-3-(3-dimethylaminopropyl)carbo-
diimide and N-hydroxysuccinimide (EDC/NHS-cross-linked BGNPs–
COL–HYA–PS). The biomineralization, degradation, and mechanical
strength of the cross-linked composite scaffolds were superior to
those of scaffolds without crosslinking. Further in vitro cell culture
studies reported thatMC3T3 cells adhered and spread on the surface
of cross-linked BGNPs–COL–HYA–PS scaffolds, showing the biocom-
patibility of the nanocomposite.27
Following this work, Xie et al. studied the in vivo bone
regeneration ability of EDC/NHS-cross-linked BGNPs–COL–HYA–PS
composite scaffolds utilizing a rabbit radius defect model.146
X-ray and histological studies confirmed the bone regeneration
ability for plain nanocomposites and nanocomposites com-
bined with growth factors. The bone defect was covered with
new bone only in the nanocomposites grafted with BMP at eight
weeks. Also, the nanocomposite combined with BMP showed
improved ectopic bone formation compared with the compo-
sites without BMP.146
Gelatin/collagen
Barabadi et al. designed a scaﬀold for myocardial tissue engi-
neering based on a blend of gelatin and collagen combined with
BGNPs. They demonstrated that the incorporation of BGNPs into
the hydrogel scaﬀold enhanced the diﬀerentiation of human
endometrial stromal cells into the endothelial lineage and
increased vascular endothelial growth factor expression, suggest-
ing a beneficial role of BGNPs for angiogenesis in myocardial
tissue engineering.147 The finding suggested that BGNPs can also
be considered for use in myocardial regeneration.
Conclusions
Regenerative medicine concepts in combination with material
science/technology have produced new high-performance bio-
materials for tissue regeneration. BGNPs and nanocomposites
have undergone considerable developments, particularly in
their synthesis, processing, and structural characterization, to
understand their interactions with cells and their applications
in tissue engineering. Also, BGNPs have been found to improve
and direct the proliferation and diﬀerentiation of odontoblasts,
cementoblasts, osteoblasts and fibroblasts. Although many studies
have been performed to restore tissues using nanoscale bioactive
glasses, these eﬀorts are still mainly confined to laboratory studies.
Also, the conjugation of nanostructured biomaterials with stem
cells and growth factors to achieve the desired goal of tissue regene-
ration is showing promising results; however, more research is
needed, especially in soft tissue reconstruction.
Significant progress is similarly being made to introduce
nanoscale bioactive glass as fillers in polymers, to use their
diﬀerent material properties synergistically, and to stimulate
tissue regeneration. An ongoing area of considerable investiga-
tion is the reproduction of nanosize features in biomaterials to
resemble specific ECM structures to enhance the biological
roles of existing polymeric biomaterials. Systems that integrate
macroscale shapes, microscale pores and nanoscale architec-
tures have been rapidly designed to optimize the function of
biomaterials. However, further exploration is needed to exploit
the novel features of these nanocomposites to address the
challenges of hard and soft tissue regeneration.
Promising research fields are the incorporation of bio-
molecules, such as growth factors, and the controlled patterning
of BGNPs within the polymeric matrix. This would provide excep-
tional control and tailoring of the mechanical and biological
properties of the nanocomposite materials.
Further improvement in new nanoscale bioactive glasses
and their combination with polymers and bioactive molecules
may provide biomimetic materials that meet the challenges of
hard and soft tissue engineering applications.
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